Skip to main content
. 2020 Mar 24;15(3):e0230627. doi: 10.1371/journal.pone.0230627

Fig 2. The expression pattern of eIF5AHyp in T2D and control pancreatic tissue.

Fig 2

In controls (matched for age, gender and BMI) and T2D pancreas, we evaluated the co-expression of eIF5AHyp with all islet hormones and found no overlap with insulin (A,B), glucagon (C,D), ghrelin (E,F) or somatostatin (G,H).